You are here

  • Home
  • Archive
  • Volume 4, Issue 1
  • Identification of sarilumab pharmacodynamic and predictive markers in patients with inadequate response to TNF inhibition: a biomarker substudy of the phase 3 TARGET study

Article metrics

Article menu

Download PDFPDF

Rheumatoid arthritis
Original article
Identification of sarilumab pharmacodynamic and predictive markers in patients with inadequate response to TNF inhibition: a biomarker substudy of the phase 3 TARGET study

 

Online download statistics by month:

Online download statistics by month: March 2018 to March 2024

AbstractFullPdf
Mar 2018331332120
Apr 201822722880
May 201820420667
Jun 201810410546
Jul 2018797951
Aug 2018616129
Sep 2018595957
Oct 2018393943
Nov 2018515143
Dec 2018363640
Jan 2019454346
Feb 2019343150
Mar 2019464353
Apr 2019393968
May 2019333326
Jun 2019252548
Jul 2019343481
Aug 2019353533
Sep 2019383642
Oct 2019424029
Nov 2019313017
Dec 2019313122
Jan 2020232316
Feb 2020272716
Mar 2020464621
Apr 2020757550
May 2020252511
Jun 2020332820
Jul 2020323022
Aug 2020292017
Sep 2020373417
Oct 202038288
Nov 2020201813
Dec 202020174
Jan 2021282610
Feb 2021383018
Mar 202131296
Apr 2021353415
May 202139325
Jun 2021322711
Jul 2021343018
Aug 2021393417
Sep 2021312813
Oct 2021353326
Nov 2021161619
Dec 2021261914
Jan 202222214
Feb 202222238
Mar 2022313017
Apr 2022232211
May 2022333212
Jun 202241408
Jul 202213134
Aug 202236364
Sep 2022333416
Oct 202238392
Nov 2022222111
Dec 202231285
Jan 2023383812
Feb 2023353516
Mar 2023524914
Apr 2023221816
May 2023303013
Jun 202338365
Jul 2023191913
Aug 2023202012
Sep 202322224
Oct 202320202
Nov 202330255
Dec 2023686713
Jan 202410102
Feb 2024202012
Mar 2024262438
Total320830971757